VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 101 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 17.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $218,000 | +156.5% | 28,650 | -9.0% | 0.01% | +27.3% |
| Q4 2021 | $85,000 | +112.5% | 31,490 | +105.5% | 0.01% | +120.0% |
| Q3 2021 | $40,000 | -87.1% | 15,320 | -47.1% | 0.01% | -94.9% |
| Q3 2020 | $309,000 | -15.3% | 28,955 | 0.0% | 0.10% | -21.0% |
| Q2 2020 | $365,000 | -54.9% | 28,955 | -67.2% | 0.12% | -63.6% |
| Q1 2020 | $809,000 | -33.9% | 88,365 | +0.7% | 0.34% | -6.8% |
| Q4 2019 | $1,224,000 | +86.0% | 87,755 | +129.6% | 0.37% | +49.4% |
| Q3 2019 | $658,000 | -7.5% | 38,215 | +46.4% | 0.24% | -6.8% |
| Q2 2019 | $711,000 | +126.4% | 26,105 | +59.3% | 0.26% | +46.9% |
| Q1 2019 | $314,000 | – | 16,390 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |